Sumitomo Life Insurance Co. Takes $749,000 Position in Agilent Technologies, Inc. $A

Sumitomo Life Insurance Co. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 5,639 shares of the medical research company’s stock, valued at approximately $749,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Fiduciary Trust Co raised its position in Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares in the last quarter. Sapient Capital LLC boosted its holdings in Agilent Technologies by 4.2% during the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after purchasing an additional 85 shares in the last quarter. Plan A Wealth LLC boosted its holdings in Agilent Technologies by 3.2% during the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock valued at $403,000 after purchasing an additional 92 shares in the last quarter. UNIVEST FINANCIAL Corp boosted its holdings in Agilent Technologies by 1.3% during the second quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock valued at $949,000 after purchasing an additional 93 shares in the last quarter. Finally, IHT Wealth Management LLC grew its stake in shares of Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after purchasing an additional 96 shares during the period.

Agilent Technologies Stock Performance

NYSE:A opened at $159.25 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.51. The firm has a 50 day moving average of $137.57 and a 200-day moving average of $126.23. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $44.98 billion, a P/E ratio of 31.98, a price-to-earnings-growth ratio of 2.81 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Morgan Stanley boosted their price target on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price target for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Jefferies Financial Group started coverage on Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective for the company. Finally, Piper Sandler started coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.